KWM
PRPH

Keebeck Wealth Management’s ProPhase Labs PRPH Stock Holding History

Keebeck Wealth Management’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,000
Closed -$193K – 257
2022
Q4 		$193K Hold
2,000
– – 0.03% 233
2022
Q3 		$226K Buy
+2,000
New +$233K 0.04% 210

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Keebeck Wealth Management's PRPH Position: Q1 2023 in Review

Keebeck Wealth Management sold out of ProPhase Labs (PRPH) in Q1 2023, closing a stake of 2,000 shares — an estimated $193K sold.

Keebeck Wealth Management first reported a position in PRPH in Q3 2022 and held it in 2 quarters. The position peaked at $226K in Q3 2022. 39 funds tracked by Wall St. Rank hold PRPH as of Q1 2023.

  • Keebeck Wealth Management reported no remaining ProPhase Labs position as of Q1 2023 after selling out during the quarter.
  • Keebeck Wealth Management sold 2,000 ProPhase Labs shares in Q1 2023, an estimated $193K.
  • Keebeck Wealth Management first reported a position in ProPhase Labs in Q3 2022 and held it in 2 quarters.
  • Keebeck Wealth Management's ProPhase Labs position peaked at $226K in Q3 2022.
  • 39 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2023.

Based on Keebeck Wealth Management's 13F filing for Q1 2023, filed 15 May 2023.